Last reviewed · How we verify
NCT03451552: ARC
Patient Navigation in Primary Care and Access to Resources in the Community
NA trial testing Patient Navigator in Health Care Inequity, Patient Navigation in 326 participants. Completed in 1 May 2019.
1 March 2019
Quick facts
| Lead sponsor | Ottawa Hospital Research Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 326 |
| Start date | 1 April 2018 |
| Primary completion | 1 March 2019 |
| Estimated completion | 1 May 2019 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Patient Navigator
Conditions studied
- Health Care Inequity, Patient Navigation — all drugs for Health Care Inequity, Patient Navigation →
Sponsor
Ottawa Hospital Research Institute
Who can join
Eligibility, any sex, with Health Care Inequity, Patient Navigation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Some people living with health problems require extra support to properly manage their conditions, as family doctors are only able to spend limited time in the office with these patients. There are many resources and programs in the community that can provide the necessary time and support for these patients, yet many patients are unaware that such resources exist. Patient navigators have been shown to be useful in helping patients with certain conditions (such as cancer) to get to the resources they need, especially when they have social challenges that make it difficult for them to reach these programs (for example, language or transportation barriers, poverty, or poor social support). This study will look at how helpful Navigators are to link patients at family doctors' offices to community resources. To do this, family doctors' offices in Ottawa and Sudbury will be recruited. All offices will receive training on directing patients to CRs and will be assigned a patient navigator to support patients access CRs. Half of the patients referred to CRs by their providers will have access to the navigator (intervention) assigned to the practice. This study will assess whether access to a navigator increases patients' access to community health and social services compared to usual standard of care. In addition, the study aims to understand whether English and French speaking individuals are as likely to benefit from a navigator in accessing community resources in the language of their choice.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Understanding patient barriers and enablers to accessing community resources: a qualitative study to inform navigation service delivery.
Saluja K, Mahbub A, Gauthier AP, Lemonde M, et al · · 2025 · cited 1× · PMID 41136927 · DOI 10.1186/s12875-025-03029-z
Verify or expand the search:
- PubMed search for NCT03451552
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Patient Navigator
Trials testing the same drug.
- NCT05286879 — Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-in · NA · completed
- NCT03342495 — Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial · NA · completed
- NCT01917747 — Promoting Early Diagnosis of Congenital Hearing Loss With Patient Navigators · NA · completed
Other Ottawa Hospital Research Institute trials
Trials by the same sponsor.
- NCT07464080 — Advanced Brain Imaging-TKA (fMRI-TKA) · NA · recruiting
- NCT07171567 — Vacuum Therapy for the Treatment of Penile Numbness/Sensory Changes · EARLY_PHASE1 · recruiting
- NCT07058025 — Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants · Phase 2 · not yet recruiting
- NCT07177833 — Title Fractioned CO2 Laser in the Treatment of Chronic Phase Peyronie's Disease · Phase 1 · recruiting
- NCT06929767 — Do Blood Tests Help to Decide Which Patients With Flares of Chronic Obstructive Pulmonary Disease (COPD) Need Antibiotic · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03451552 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ottawa Hospital Research Institute
- Last refreshed: 19 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03451552.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing